✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Shanghai Fosun Pharmaceutical Group Co Ltd

Common Name
Fosun Pharma
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
40,557
Ticker
600196
Exchange
SHANGHAI STOCK EXCHANGE
Description
Shanghai Fosun Pharmaceutical Group Co., Ltd. is a leading enterprise in the pharmaceutical and healthcare industry, operating across a diverse range of sectors. Its primary function involves the rese...

Disclosures of Fosun Pharma

Explore Fosun Pharma's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Fosun Pharma's official channels and fully traceable to its official company sources.

The table below lists all of Fosun Pharma's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

If you want to search across Fosun Pharma's' disclosures for specific data or insights, use our Disclosure Search.

NameReporting Period
ESG Report
2024
Annual Report
2024
Annual Report
2023
ESG Report
2023
CSR Report
2022
Annual Report
2022
Annual Report
2021
CSR Report
2021
ESG Report
2021
Annual Report
2020
ESG Report
2020
CSR Report
2020
Annual Report
2019
CSR Report
2019
Annual Report
2018
CSR Report
2018
Annual Report
2017
CSR Report
2017
CSR Report
2016
Annual Report
2015
CSR Report
2015
Annual Report
2014
CSR Report
2014
Responsibility Report
2013
Annual Report
2013
Annual Report
2012
Responsibility Report
2012
Responsibility Report
2011
Responsibility Report
2010
Responsibility Report
2009
Responsibility Report
2008
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?